Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Black Point Group is a private investment firm based in Portland, Maine, founded by David Shaw, the visionary founder and former CEO of IDEXX Laboratories. The firm specializes in building and investing in high-growth companies, with a primary focus on the life sciences, animal health, and healthcare technology sectors. Black Point Group distinguishes itself by taking an active, long-term leadership role in its portfolio companies, leveraging extensive experience in scaling global science-based enterprises. Notable successes associated with the firm include the growth of IDEXX and the formation of Covetrus through Vets First Choice. Their investment philosophy centers on disruptive innovations that enhance health outcomes and improve professional productivity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Black Point Group.